APAC (Asia-Pacific)

SHERIDAN, WYOMING - December 19, 2025 - Bristol Myers Squibb (BMS) has struck a potential $1B-plus partnership with Harbour BioMed to collaborate on next-generation multi-specific antibody programs, underscoring how China-based innovation is increasingly shaping global biologics dealmaking.

Deal scope and economics in brief
BMS will pay $90 million upfront to work with Harbour on developing and advancing multi-specific antibody therapies, with additional development and commercial milestones that could total up to $1.035 billion. The partners did not disclose how many programs are covered, nor did they specify initial targets, indications, or therapeutic areas.

For business development teams and portfolio planners, the structure reflects a familiar "platform-plus-programs" model: BMS buys early discovery leverage and optionality, while Harbour positions itself for milestone upside and downstream royalties if programs progress.

SHERIDAN, WYOMING - December 15, 2025 - Dubai Airshow 2025 opened at Dubai World Central with the Middle East debut of two of China's homegrown C919 aircraft, signaling a higher-profile push by Chinese aerospace players to showcase commercial, unmanned, and next-generation aviation technologies to global buyers.

C919 debut puts China's narrowbody on a new international stage
At the 19th edition of the Dubai Airshow, the appearance of the C919 marked its first showing in the Middle East, with a flight demonstration at the venue. The aircraft's presence matters beyond the air display: for airlines, lessors, MRO providers, and airport stakeholders, international showcases help shape early market perception around supply-chain maturity, support ecosystems, and longer-term export ambitions.

SHERIDAN, WYOMING - December 15, 2025 - ARIDGE has introduced new details on its next-generation A868 flying car concept and confirmed fresh progress at its flying car manufacturing plant, as the company positions two flight systems to serve different segments of China's emerging low-altitude mobility market.

Two flight systems target distinct low-altitude travel needs
ARIDGE framed the low-altitude economy as the next major growth frontier following new energy vehicles, and outlined a dual-product strategy built around different operating missions. The company is developing:

SHERIDAN, WYOMING - December 15, 2025 - XPENG AEROHT, the flying car affiliate of Chinese EV maker XPENG, has begun trial production at what it describes as the world's first intelligent factory for mass-produced flying cars-an operational milestone as next-generation mobility moves from prototypes to industrial output.

Trial production signals a commercialization inflection point
The company started trial production on November 3, 2025, positioning the facility as a bridge between engineering validation and repeatable manufacturing. For the broader eVTOL and "low-altitude mobility" ecosystem, factory readiness matters because it shifts the discussion from flight demonstrations to supply chains, quality systems, and scalable assembly-areas that typically determine whether new vehicle categories can reach customers on schedule.

SHERIDAN, WYOMING - December 15, 2025 - Shanghai is sharpening its push to become a leading center for merger-and-acquisition activity, as the 2025 Mergers and Acquisitions Finance Conference spotlighted stronger regional deal momentum and unveiled a new market index intended to track China's evolving M&A environment.

Policy momentum behind listed-company restructuring
The conference took place as Shanghai marks one year since releasing a three-year action plan aimed at supporting M&A among listed firms. In practical terms, the message to corporate leaders and capital providers is clear: policy alignment and financial-market infrastructure are being positioned to support more transactions that improve efficiency, accelerate industrial upgrading, and strengthen competitiveness in key sectors.

SHERIDAN, WYOMING - December 10, 2025 - Pfizer Inc. is expanding its cardiometabolic ambitions through an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical, to develop, manufacture and commercialize YP05002, an oral GLP-1 receptor agonist currently in Phase 1 for chronic weight management. The deal strengthens Pfizer's position in the fast-moving obesity field and adds a differentiated small-molecule asset to its portfolio of metabolic disease candidates.

Strategic Bet on Small-Molecule GLP-1 in Obesity

Under the agreement, China-based YaoPharma will complete an ongoing Phase 1 study of YP05002 before transferring global development and commercialization rights to Pfizer. For Pfizer, the asset fits neatly into a strategy that aims to pair novel mechanisms with scalable, oral delivery formats for obesity and adjacent cardiometabolic conditions.

SHERIDAN, WYOMING - December 10, 2025 - Yupp Video Services (YVS), the B2B technology arm of YuppTV, is stepping up its role as a white-label OTT backbone provider by delivering a full-stack platform overhaul for Chaupal, one of India's fastest-growing regional streaming services for Punjabi, Haryanvi and Bhojpuri content. The partnership is designed to harden reliability, boost performance and modernize user experience as Chaupal enters its next aggressive growth phase.

Full Technology Replatforming for High-Growth Regional OTT

After three years of rapid subscriber expansion, Chaupal reached the limits of its existing technology stack and needed an infrastructure built for scale, multi-device reach and operational resilience. Yupp Video Services responded with a fully custom instance of its OTT platform tailored to Chaupal's regional content strategy and monetization model.

SHERIDAN, WYOMING - December 10, 2025 - SK Chemicals is moving to secure full control over its circular plastics value chain by vertically integrating feedstock sourcing through a new joint venture and Feedstock Innovation Center (FIC) in China, positioning its depolymerization-based chemical recycling business for stronger cost competitiveness and supply stability across Asia-Pacific.

From Depolymerization Pioneer to Fully Integrated Circular Plastics Player

SK Chemicals has signed a joint venture agreement with Shaanxi-based recycler Kelinle to build the Feedstock Innovation Center, a dedicated facility for processing waste plastics into recycled raw materials. Located on an idle 13,200 m² site in Weinan, Shaanxi Province, the FIC will convert end-of-life plastics into PET pellets that feed SK Chemicals' depolymerization process.

SHERIDAN, WYOMING - December 10, 2025 - VisIC Technologies has raised $26 million in a Round B financing that positions its Gallium Nitride (GaN) power devices at the center of the next wave of electric vehicle (EV) drivetrain innovation for global automotive and mobility markets. Led by a global semiconductor leader with Hyundai Motor Company and Kia (HKMC) joining as strategic investor, the funding will help VisIC industrialize its D³GaN™ platform for high-volume traction inverters and adjacent high-voltage applications.

GaN Steps Forward as EV OEMs Push Beyond Silicon and SiC

SHERIDAN, WYOMING - December 10, 2025 - Hanwha Finance is sharpening its Middle East growth agenda as Chief Global Officer Dong-Won Kim used his opening address at Abu Dhabi Finance Week's Global Markets Summit to position South Korea-UAE financial collaboration as a long-term strategic pillar for both economies and a testbed for next-generation digital capital markets.

Strengthening a Korea-UAE "100-Year Partnership" Through Finance

Speaking in Abu Dhabi, Kim framed financial services as the connective tissue that will turn high-level Korea-UAE diplomacy into investable projects and new cross-border capital flows. He noted that "since the establishment of diplomatic relations in 1980, South Korea and the UAE have continuously expanded the scope of cooperation", and stressed that Hanwha Finance intends to help carry forward a "100-year partnership" between the two nations.